Innovation in Drug Delivery: The future of nanotechnology and non-invasive protein delivery

Innovation in Drug Delivery provides an in-depth examination of product launches and pipeline drugs with novel drug delivery mechanisms set to revolutionize the market, such as products using ALZA Corporation’s E-TRANS and Altea’s PassPort patch transdermal technologies.

This report will enable you to evaluate key marketed drugs, including Emend and Megace, and gain an insight into novel pipeline products to anticipate upcoming product launches and position yourself for success.Use this report to understand how nanotechnology and other key technologies are changing drug delivery and how these can be implemented into your R&D process. Assess the impact of innovation in therapy areas including oncology, diabetes and infectious diseases and identify future opportunities for market growth.

Read more...

• Leading Drug Delivery Companies and Technologies (14/10/2008)
• Management of Diabetes (14/10/2008)
• Obesity Drug Markets (14/10/2008)

• NNRTIs (16/05/2008)
• Non-Hodgkin's Lymphoma (16/05/2008)
• Multiple Myeloma (16/05/2008)

• Next-Generation Nutraceuticals (15/05/2008)
• Innovations in CNS (15/05/2008)
• Protein Engineering & Drug Design (14/05/2008)
• Winning Product Launch Strategies (14/05/2008)
• Drug Repositioning Strategies (14/05/2008)
• Outlook for RNAi (14/05/2008)
• Targeted Cancer Therapies (14/05/2008)
• The Future of Biosimilars (14/05/2008)
• Cardiovascular Disease Management (14/05/2008)

---